Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Oct 13, 2020 10:35pm
101 Views
Post# 31712063

RE:RE:RE:RE:Mr. Market is wrong on this?

RE:RE:RE:RE:Mr. Market is wrong on this?I'm not a subject matter expert but likely because BG is not a drug, and non toxic so a preclinical study was not needed; in addition there have been more than enough papers on the benefits of BG. If the experts at MHI agreed to put their name on this study, that's good enough for me.  The only concern was it's interaction with statins, but with the change to allow some patients to use it as a stand alone therapy, we are more likely to have significantly positive results conducted using the good standard to show statistically significant results.

From Wikipedia:

The main goals of preclinical studies are to determine a starting, safe dose for first-in-human study and assess potential toxicity of the product, which typically include new medical devicesprescription drugs, and diagnostics.

Minty_33 wrote: Ciao said...Every now and then I need to remind myself that the prize is still the BG pill....

Spin the wheel, because it could be a total flop. How come there has been zero pre-clinical data released? Can anybody on this board answer that? ......



<< Previous
Bullboard Posts
Next >>